183 related articles for article (PubMed ID: 31773659)
1. HMG-CoA Reductase as Target for Drug Development.
Gunasekaran B; Shukor MY
Methods Mol Biol; 2020; 2089():245-250. PubMed ID: 31773659
[TBL] [Abstract][Full Text] [Related]
2. In-silico HMG-CoA reductase-inhibitory and in-vivo anti-lipidaemic/anticancer effects of carotenoids from Spondias mombin.
Metibemu DS; Akinloye OA; Akamo AJ; Okoye JO; Omotuyi IO
J Pharm Pharmacol; 2021 Sep; 73(10):1377-1386. PubMed ID: 34343336
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitory activity and phytocomponent investigation of Basella alba leaf extract as a treatment for hypercholesterolemia.
Baskaran G; Salvamani S; Ahmad SA; Shaharuddin NA; Pattiram PD; Shukor MY
Drug Des Devel Ther; 2015; 9():509-17. PubMed ID: 25609924
[TBL] [Abstract][Full Text] [Related]
4. Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait.
Iqbal D; Khan MS; Khan MS; Ahmad S; Hussain MS; Ali M
Lipids Health Dis; 2015 Mar; 14():15. PubMed ID: 25884722
[TBL] [Abstract][Full Text] [Related]
5. Structural mechanism for statin inhibition of HMG-CoA reductase.
Istvan ES; Deisenhofer J
Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
[TBL] [Abstract][Full Text] [Related]
6. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
[TBL] [Abstract][Full Text] [Related]
7. Green and black tea extracts inhibit HMG-CoA reductase and activate AMP kinase to decrease cholesterol synthesis in hepatoma cells.
Singh DK; Banerjee S; Porter TD
J Nutr Biochem; 2009 Oct; 20(10):816-22. PubMed ID: 18926682
[TBL] [Abstract][Full Text] [Related]
8. Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia.
Wu N; Sarna LK; Siow YL; O K
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R635-43. PubMed ID: 21178122
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.
Weber C; Erl W; Weber KS; Weber PC
J Am Coll Cardiol; 1997 Nov; 30(5):1212-7. PubMed ID: 9350917
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
12. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
Peffley DM; Gayen AK
J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
[TBL] [Abstract][Full Text] [Related]
13. Mode of interaction of beta-hydroxy-beta-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds.
Nakamura CE; Abeles RH
Biochemistry; 1985 Mar; 24(6):1364-76. PubMed ID: 3886005
[TBL] [Abstract][Full Text] [Related]
14. Phytoconstituents of an ethanolic pod extract of Prosopis cineraria triggers the inhibition of HMG-CoA reductase and the regression of atherosclerotic plaque in hypercholesterolemic rabbits.
Ram H; Jaipal N; Charan J; Kashyap P; Kumar S; Tripathi R; Singh BP; Siddaiah CN; Hashem A; Tabassum B; Abd Allah EF
Lipids Health Dis; 2020 Jan; 19(1):6. PubMed ID: 31931807
[TBL] [Abstract][Full Text] [Related]
15. An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia.
Gesto DS; Pereira CMS; Cerqueira NMFS; Sousa SF
Molecules; 2020 Aug; 25(17):. PubMed ID: 32859023
[TBL] [Abstract][Full Text] [Related]
16. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase from Haloferax volcanii: purification, characterization, and expression in Escherichia coli.
Bischoff KM; Rodwell VW
J Bacteriol; 1996 Jan; 178(1):19-23. PubMed ID: 8550415
[TBL] [Abstract][Full Text] [Related]
17. Investigation of HMG-CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives.
Ozalp L; Danış Ö; Yuce-Dursun B; Demir S; Gündüz C; Ogan A
Arch Pharm (Weinheim); 2020 Oct; 353(10):e1900378. PubMed ID: 32648617
[TBL] [Abstract][Full Text] [Related]
18. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts.
Honda A; Salen G; Honda M; Batta AK; Tint GS; Xu G; Chen TS; Tanaka N; Shefer S
J Lab Clin Med; 2000 Feb; 135(2):174-9. PubMed ID: 10695663
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of HMG-CoA Reductase: Current and Future Prospects.
Singh N; Tamariz J; Chamorro G; Medina-Franco JL
Mini Rev Med Chem; 2009 Oct; 9(11):1272-83. PubMed ID: 19929805
[TBL] [Abstract][Full Text] [Related]
20. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.
Kita T; Brown MS; Goldstein JL
J Clin Invest; 1980 Nov; 66(5):1094-100. PubMed ID: 6903572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
